メニュー
JP | JPY
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
JP | JPY
Sorry, we couldn't find anything on our website containing your search term.

Eppendorf AG completes conversion to European public limited company
news
- プレスリリース
- Conversion to SE ("Societas Europaea") completed
- No impact on current business
- Group headquarter remains in Hamburg, Germany
Hamburg, October 19, 2021 – The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE with immediate effect.
"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in large family-owned companies," said Eva van Pelt and Dr. Peter Fruhstorfer, Co-CEOs of Eppendorf SE. "The company's name as a European public limited company is a clear signal that even more strongly expresses Eppendorf's global corporate culture. In addition, the new legal form shows that Eppendorf is an international company and that national borders play less and less of a role for us."
The new company name as Eppendorf SE demonstrates the company's further development into a modern, progressive, and internationally active European company, the CEOs added. Also, it provides important support that will enable Eppendorf to continue its global success course even more effectively, they said.
The conversion into a Societas Europaea will not result in any changes to the company's structure. Management Board and Supervisory Board members continue to work for Eppendorf SE. Eppendorf's Group headquarters will remain in Hamburg, Germany, and the character of an independent family-owned company will be preserved.
もっと読む
表示を減らす